As of 2026, many GLP-1 lawsuits are consolidated into multidistrict litigation (MDL), which can influence the overall timeline
However, dozens of lawsuits allege that Mounjaro caused patients to suffer unexpected and severe side effects, such as gastroparesis and bowel blockages
However, current evidence suggests that certain groups may have the most to gain
Benefits of Exercise and GLP-1 Therapy According to the research, exercise and GLP-1 therapy can: Generate $182 million in health and economic value over 10 years Deliver a 59 per cent return on investment within 10 years Generate $1.4 billion in value over 30 years Deliver a 457 per cent return on investment over 30 years Improve long-term health outcomes Reduce future healthcare costs Preserve muscle mass, strength, mobility and bone health Improve long-term weight maintenance Reduce weight regain after treatment ends Prevent hundreds of serious health events, including heart attacks, strokes and heart failure Reduce the need for knee and hip replacements A Call to Integrate Exercise and GLP-1 Therapy In response to the findings, AUSactive has joined leading industry organisations from Australia, New Zealand, Canada, the United Kingdom and the United States
Neuroprotective effects of a GIP analogue in the MPTP Parkinsons disease mouse model
Its Body program includes access to compounded semaglutide along with coaching and lifestyle support tools
